Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact email@example.com
SOURCE Research and Markets
DUBLIN, March 5, 2018 /PRNewswire/ --
The "Non-opioid Pain Treatment: Global Markets to 2022" report has been added to ResearchAndMarkets.com's offering.
This report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for pain management. The geographical scope of this study is global. This study addresses acute versus chronic pain, treatments and regulatory issues facing healthcare workers. Also provided is detailed information based on product categories, use of products, forecasts and competitive analyses.
The report identifies five general product segments for non-opioid treatment of pain:
Within the segment several sub-segments are discussed as they pertain to each product segment; diseases or disorders are the basis for these sub-segments, including:
Each market segment provides detailed information based on product categories, product use, current market value and forecasts.
For more information about this report visit https://www.researchandmarkets.com/research/qh6g72/nonopioid_pain?w=5
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
©2017 PR Newswire. All Rights Reserved.